“We proactively pursued the amendment to our Seller’s License to include copyright again in December 2022. We will Assess how the commercialization of the substance suits in with our business model at Adastra in order to situation ourselves to assist the demand from customers for a safe provide of copyright,” Adastra said in an announcement.